When comparing serous ovarian cancer primary tissue cells to those obtained from the patient’s ascites, Ortolan et al. were able to note that nearly all the primary tumor cells expressed CD157, yet only 10% of the cells isolated from ascites expressed CD157. This evidence concerns the gene BST1 and neoplasm.